Clinical Trials Browser

Phase 1/2 × Albumin-Bound Paclitaxel × Plasma cell × Clear all

NCT02075021 2018-10-15

rev/abraxane

Phase 1/2 Terminated

3 enrolled 3 charts

Multiple Myeloma, Recurrence